Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis

NJ Maney, H Lemos, B Barron-Millar, Christopher Carey, I Herron, Amy Anderson, Andrew Mellor, John Isaacs, Arthur Pratt

Open source

DOI
10.25405/ncl.34439901.v1
Published
2026
Container
Not recorded
Publisher
Newcastle University
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.25405/ncl.34439901.v1,
  title = {Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis},
  author = {NJ Maney and H Lemos and B Barron-Millar and Christopher Carey and I Herron and Amy Anderson and Andrew Mellor and John Isaacs and Arthur Pratt},
  year = {2026},
  doi = {10.25405/ncl.34439901.v1},
  url = {https://doi.org/10.25405/ncl.34439901.v1}
}

RIS

TY  - JOUR
TI  - Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis
AU  - NJ Maney
AU  - H Lemos
AU  - B Barron-Millar
AU  - Christopher Carey
AU  - I Herron
AU  - Amy Anderson
AU  - Andrew Mellor
AU  - John Isaacs
AU  - Arthur Pratt
PY  - 2026
DO  - 10.25405/ncl.34439901.v1
UR  - https://doi.org/10.25405/ncl.34439901.v1
ER  - 

APA

Maney, N., Lemos, H., Barron-Millar, B., Carey, C., Herron, I., Anderson, A., Mellor, A., Isaacs, J., & Pratt, A. (2026). Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis. https://doi.org/10.25405/ncl.34439901.v1

Source records